Measurement of monocyte apoptosis, plasma IL-1β and PR3 activity as an approach to evaluate the immunological status in sepsis

  • Hong-Ping Qu1Email author,

    Affiliated with

    • Zhao-Jun Liu1 and

      Affiliated with

      • Jia-Lin Liu1

        Affiliated with

        Critical Care201115:434

        DOI: 10.1186/cc10248

        Published: 28 June 2011

        In a previous issue of Critical Care, Giamarellos-Bourboulis and colleagues published an article in which they drew a conclusion that inhibition of caspase-1 and defective IL-1β production is an important immunological feature in sepsis [1]. Based on the knowledge of previous research, we would like to make some remarks.

        Firstly, peripheral blood mononuclear cells (PBMC) mainly consist of monocytes, T cells, B cells and natural killer cells, of which only monocytes are the high producer of IL-1β and TNFα. The proportion of monocytes in PBMC may therefore greatly affect production of these cytokines. In earlier research, Giamarellos-Bourboulis and colleagues demonstrated that the percentage of monocyte apoptosis was over 50% in about half of their septic subjects [2]. In their recent study, however, these authors found that downregulation of IL-1β followed a different pattern to TNFα; release of TNFα was not impaired after lipopolysaccharide stimulation of PBMC of patients with uncomplicated sepsis and with severe sepsis [1], suggesting that the monocytes of these subjects did not undergo apoptosis. The introduction of methods to check the apoptosis of monocytes and their proportion in PBMC is thus quite necessary.

        Secondly, the authors concluded that defective IL-1β production is an important immunological feature in sepsis. According to Fahy and colleagues' research, however, the plasma IL-1β level was significantly elevated in patients with septic shock in comparison with normal control subjects [3]. A possible explanation for this difference is that caspase-1 is not the unique enzyme that can activate IL-1β. Recent studies suggest that neutrophils are the major source for processing IL-1β via PR3 during acute inflammatory conditions [4]. To reveal the real immunological status in sepsis, therefore, it would be better in future research to measure the plasma IL-1β level and the activity of PR3 in neutrophils in septic patients simultaneously, in addition to ex vivo experiments.

        Abbreviations

        IL: 

        interleukin

        PBMC: 

        peripheral blood mononuclear cells

        TNF: 

        tumor necrosis factor

        Declarations

        Authors’ Affiliations

        (1)
        Department of Critical Care Medicine and Respiratory Intensive Care Unit, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine

        References

        1. Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG: Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 2011, 15:R27.PubMedView Article
        2. Giamarellos-Bourboulis EJ, Routsi C, Plachouras D, Markaki V, Raftogiannis M, Zervakis D, Koussoulas V, Orfanos S, Kotanidou A, Armaganidis A, Roussos C, Giamarellou H: Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? Crit Care 2006, 10:R76.PubMedView Article
        3. Fahy RJ, Exline MC, Gavril in MA, Bhatt NY, Besecker BY, Sarkar A, Hollyfield JL, Duncan MD, Nagaraja HN, Knatz NL, Hall M, Wewers MD: Inflammasome mRNA expression in human monocytes during early septic shock. Am J Respir Crit Care Med 2008, 177:983–988.PubMedView Article
        4. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA: Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol 2011, 32:110–116.PubMedView Article

        Copyright

        © BioMed Central Ltd 2011

        Advertisement